Prokocimer Philippe 4
4 · Trius Therapeutics Inc · Filed Mar 27, 2012
Insider Transaction Report
Form 4
Prokocimer Philippe
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2012-03-23−6,244→ 0 totalExercise: $0.52Exp: 2018-01-09→ Common Stock (6,244 underlying) - Exercise/Conversion
Common Stock
2012-03-23$0.52/sh+6,244$3,247→ 98,022 total(indirect: By Trust)
Holdings
- 9,499
Common Stock
Footnotes (1)
- [F1]25% of the shares subject to the 14,244 share option grant vested on 1/1/09, with the remainder vesting monthly thereafter until fully vested on 1/1/12.